Moore Capital Management’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Moore Capital Management’s Portfolio DRTSW Stock Details DRTSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$443K	Sell	150,000 -25,000	-14%	-$41.6K	0.01%	538
2026 Q1	$175K	Hold	175,000	–	–	﹤0.01%	470
2025 Q4	$59.5K	Hold	175,000	–	–	﹤0.01%	580
2025 Q3	$60.4K	Hold	175,000	–	–	﹤0.01%	550
2025 Q2	$38.5K	Hold	175,000	–	–	﹤0.01%	493
2025 Q1	$41.6K	Hold	175,000	–	–	﹤0.01%	427
2024 Q4	$36.8K	Hold	175,000	–	–	﹤0.01%	458
2024 Q3	$35K	Hold	175,000	–	–	﹤0.01%	407
2024 Q2	$36.8K	Hold	175,000	–	–	﹤0.01%	392
2024 Q1	$38.7K	Hold	175,000	–	–	﹤0.01%	379
2023 Q4	$33.4K	Hold	175,000	–	–	﹤0.01%	355
2023 Q3	$45.5K	Hold	175,000	–	–	﹤0.01%	403
2023 Q2	$69.1K	Hold	175,000	–	–	﹤0.01%	400
2023 Q1	$57.2K	Hold	175,000	–	–	﹤0.01%	370
2022 Q4	$43.8K	Hold	175,000	–	–	﹤0.01%	405
2022 Q3	$75K	Hold	175,000	–	–	﹤0.01%	473
2022 Q2	$90K	Buy	175,000 +25,000	+17%	+$13.9K	﹤0.01%	462
2022 Q1	$92K	Buy	+150,000	New	+$81.8K	﹤0.01%	553

Other funds holding DRTSW

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

CWM

Circle Wealth Management Summit, New Jersey $7.96B AUM 30.85% 1-Year Est. Return

Moore Capital Management's DRTSW Position: Q2 2026 in Review

Moore Capital Management reduced its Alpha Tau Medical Warrant (DRTSW) stake by 14% in Q2 2026, selling an estimated $41.6K and leaving 150,000 shares worth $443K. The position accounts for 0.01% of the portfolio, ranked #538.

Moore Capital Management first reported a position in DRTSW in Q1 2022 and has held it in 18 quarters since. 21 funds tracked by Wall St. Rank hold DRTSW as of Q2 2026.

Moore Capital Management held 150,000 shares of Alpha Tau Medical Warrant worth $443K as of Q2 2026.
Moore Capital Management sold 25,000 Alpha Tau Medical Warrant shares in Q2 2026, an estimated $41.6K.
Alpha Tau Medical Warrant made up 0.01% of Moore Capital Management's portfolio in Q2 2026, its #538 holding.
Moore Capital Management first reported a position in Alpha Tau Medical Warrant in Q1 2022 and has held it in 18 quarters since.
21 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2026.

Based on Moore Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.